コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 otency of geldanamycin, but did not affect L-alanosine.
2 and other MTAP-deficient malignancies with L-alanosine.
6 ells are more sensitive to the toxicity of L-alanosine, an inhibitor of de novo AMP synthesis, than a
9 rve as a predictor of cellular response to L-alanosine and glutathione-mediated resistance to geldana
10 rian SK-OV-3 cells, reduced the potency of L-alanosine and lowered intracellular glutathione levels.
11 e correlations, e.g., amino acid analogue, L-alanosine, and 296 with negative correlations, e.g., gel
12 e that SLC7A11 mediates cellular uptake of L-alanosine but confers resistance to geldanamycin by supp
14 t strongly supports the kinetic results that alanosine did not inhibit the carbamylation of aspartate
16 ctive agent for salvaging MTAP+ cells from L-alanosine toxicity and is superior to MTA due to lower c
18 electively rescued MTAP+ MOLT-4 cells from L-alanosine toxicity at 25 microM with negligible toxicity
19 TAP+ primary T-ALL cells were rescued from L-alanosine toxicity by the MTAP substrate 5'-deoxyadenosi
20 rinsically MTAP+, would be protected from L.-alanosine toxicity, whereas MTAP-tumor cells would be ki
23 MTAP-primary T-ALL cells was inhibited by L-alanosine with a mean IC50 of 4.8+/-5.3 ILM (range, 0.3-
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。